Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
29 pending office actions • 22 art units • 27 examiners • 0 of 29 (0%) have an AI response strategy ready • 17 patents granted in the last 365 days
Mcmaster University has 28 pending office actions in Biotechnology & Pharmaceuticals. The matters span 26 distinct examiners and 21 distinct art units, reflecting a large and widely distributed prosecution docket.
SUN, CAITLYN MINGYUN is the busiest examiner, with 2 pending matters. The limited concentration at that examiner does not replace the need for structured tracking across the many examiner and art-unit assignments.
Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (3%) |
| §103 only | 6 (21%) |
| §102 only | 3 (10%) |
| §112 only | 2 (7%) |
| Double-patenting + other | 4 (14%) |
| Multi-statute (no §101) | 13 (45%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SUN, CAITLYN MINGYUN | 2 | 63.7% | +11.8% |
| KINSEY WHITE, NICOLE ERIN | 2 | 58.1% | +16.5% |
| EMPIE, NATHAN H | 1 | 43.4% | +43.3% |
| NOAKES, SUZANNE MARIE | 1 | 73.4% | +18.3% |
| SETZER, NICHOLAS LEE | 1 | 68.2% | +41.2% |
| REGLAS, GILLIAN CHELSEA | 1 | 32.3% | +37.5% |
| GEMBEH, SHIRLEY V | 1 | 63.1% | +33.8% |
| RASHID, MAHBUBUR | 1 | 67.8% | +20.5% |
| EVANS, CHRISTOPHER RYAN | 1 | 60.9% | +64.3% |
| NATARAJAN, MEERA | 1 | 62.6% | +17.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18683559 | FLUORINE-FREE SUPERHYDROPHOBIC SURFACES, METHODS OF MAKING AND USES THEREOF | NELSON, MICHAEL B | 162d overdue |
| 17923118 | MOLECULAR TRANSPORT FOR VIRAL AGENTS | KINSEY WHITE, NICOLE ERIN | 100d overdue |
| 18198154 | Compositions to Modify Intestinal Nutrient Absorption, Methods of Making and Uses Thereof | FUBARA, BLESSING M | 74d overdue |
| 18001828 | Genetically Modified Bovine Herpesvirus Type 1 (BHV-1) for use to Treat Cancer | KIM, TAEYOON | 19d overdue |
| 18627878 | ROADWAY INCIDENT SEVERITY ESTIMATION FOR TRAFFIC MANAGEMENT | JONES, ANDREW B | 15d overdue |
| 18010878 | CLEAVAGE-AMPLIFICATION BIOSENSOR AND METHODS OF USE THEREOF | KAPUSHOC, STEPHEN THOMAS | 71d |
| 18872220 | Thrombolytic Protease Resistant ADAMTS13 Mutants | NOAKES, SUZANNE MARIE | — |
| 18846459 | Bioinks for 3D Extrusion Bioprinting, Methods of Making and Uses Thereof | GEMBEH, SHIRLEY V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18026043 | ELECTROCHEMICAL BIOSENSOR FOR TARGET ANALYTE DETECTION | SUN, CAITLYN MINGYUN | 150d overdue |
| 17923118 | MOLECULAR TRANSPORT FOR VIRAL AGENTS | KINSEY WHITE, NICOLE ERIN | 100d overdue |
| 18924564 | SCALABLE FABRICATION OF A SELF-ASSEMBLED CELL SHEET AND USES THEREOF | REGLAS, GILLIAN CHELSEA | 21d |
| 19559279 | ULTRA SOFT CUTTING TOOL COATINGS AND COATING METHOD | EMPIE, NATHAN H | — |
| 18872220 | Thrombolytic Protease Resistant ADAMTS13 Mutants | NOAKES, SUZANNE MARIE | — |
| 18965198 | ROTOR CONFIGURATION HAVING FLUX BARRIER SHAPE TO IMPROVE INTERIOR PERMANENT MAGNET SYNCHRONOUS MOTOR ROTOR TORQUE PERFORMANCE | SETZER, NICHOLAS LEE | — |
| 18846459 | Bioinks for 3D Extrusion Bioprinting, Methods of Making and Uses Thereof | GEMBEH, SHIRLEY V | — |
| 18841122 | PORTABLE ELECTROCHEMICAL DEVICE FOR BIOSENSING AND METHODS OF MAKING AND USES THEREOF | SUN, CAITLYN MINGYUN | — |
| Art Unit | Apps |
|---|---|
| 1653 | 2 |
| 1795 | 2 |
| 1677 | 2 |
| 2838 | 2 |
| 1672 | 2 |
| 1613 | 2 |
| 1683 | 2 |
| 1715 | 1 |
| 2834 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19559279 | ULTRA SOFT CUTTING TOOL COATINGS AND COATING METHOD | EMPIE, NATHAN H | 1715 | §102§103DP | Non-Final OA | — | Pending | Mar 06, 2026 |
| 18872220 | Thrombolytic Protease Resistant ADAMTS13 Mutants | NOAKES, SUZANNE MARIE | 1653 | §102§112 | Non-Final OA | — | Pending | Dec 05, 2024 |
| 18965198 | ROTOR CONFIGURATION HAVING FLUX BARRIER SHAPE TO IMPROVE INTERIOR PERMANENT MAGNET SYNCHRONOUS MOTOR ROTOR TORQUE PERFORMANCE | SETZER, NICHOLAS LEE | 2834 | §102 | Non-Final OA | — | Pending | Dec 02, 2024 |
| 18924564 | SCALABLE FABRICATION OF A SELF-ASSEMBLED CELL SHEET AND USES THEREOF | REGLAS, GILLIAN CHELSEA | 1632 | §103Other | Non-Final OA | 21d | Pending | Oct 23, 2024 |
| 18846459 | Bioinks for 3D Extrusion Bioprinting, Methods of Making and Uses Thereof | GEMBEH, SHIRLEY V | 1742 | §102§103 | Non-Final OA | — | Pending | Sep 12, 2024 |
| 18841122 | PORTABLE ELECTROCHEMICAL DEVICE FOR BIOSENSING AND METHODS OF MAKING AND USES THEREOF | SUN, CAITLYN MINGYUN | 1795 | §103§112 | Non-Final OA | — | Pending | Aug 23, 2024 |
| 18756668 | IMPACT PROTECTION STRUCTURE | RASHID, MAHBUBUR | 3616 | §103§112 | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18710416 | MAGNETIC MICROGEL BEADS, METHODS OF MAKING AND USES THEREOF | EVANS, CHRISTOPHER RYAN | 1677 | §102§103§112 | Non-Final OA | — | Pending | May 15, 2024 |
| 18706314 | PRODUCTS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA | NATARAJAN, MEERA | 1643 | §112 | Non-Final OA | — | Pending | Apr 30, 2024 |
| 18627878 | ROADWAY INCIDENT SEVERITY ESTIMATION FOR TRAFFIC MANAGEMENT | JONES, ANDREW B | 2667 | §103§112 | Final Rejection | 15d overdue | Pending | Apr 05, 2024 |
| 18696755 | Hydrogel Microstructure Arrays, Methods of Making and Uses Thereof | SAEED, ALI S | 1616 | §102§103§112DP | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18600226 | A CO-PLANAR TRANSFORMER AND WINDING CONFIGURATION | LEWIS, MONICA | 2838 | §103 | Non-Final OA | 43d overdue | Pending | Mar 08, 2024 |
| 18683559 | FLUORINE-FREE SUPERHYDROPHOBIC SURFACES, METHODS OF MAKING AND USES THEREOF | NELSON, MICHAEL B | 1787 | §102§103 | Non-Final OA | 162d overdue | Pending | Feb 14, 2024 |
| 18431041 | Method for Diagnosing and Assessing Endometriosis | BORGEEST, CHRISTINA M | 1675 | §103 | Non-Final OA | 60d overdue | Pending | Feb 02, 2024 |
| 18572235 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY PHENYL COMPOUNDS | BONAPARTE, AMY C | 1692 | §102§103§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18541124 | DUAL-ACTIVE BRIDGE CONVERTER AND APPLICATIONS OF SAME | AHMED, YUSEF A | 2838 | §103 | Final Rejection | 14d | Pending | Dec 15, 2023 |
| 18565957 | CELL-FREE REGIONS BY LABEL-FREE MAGNETIC EXCLUSION | LANKFORD JR, LEON B | 1633 | §103 | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18383687 | COVALENT IMMUNE RECRUITER COMPOUNDS FOR IMMUNE CELL RECOGNITION AND ASSOCIATED USES | JACKSON, SHAWQUIA | 1626 | §112DP | Non-Final OA | — | Pending | Oct 25, 2023 |
| 18286732 | FUNCTIONALIZED BIOLOGICAL MEMBRANES WITH MODIFYING PROTEIN MOLECULES, AND METHODS OF MAKING AND USES THEREOF | KINSEY WHITE, NICOLE ERIN | 1672 | §102 | Non-Final OA | — | Pending | Oct 12, 2023 |
| 18476828 | BICARBONATE AS A POTENTIATOR FOR ANTIMICROBIAL AGENTS | STEVENS, MARK V | 1613 | §102Other | Final Rejection | — | Pending | Sep 28, 2023 |
| 18198154 | Compositions to Modify Intestinal Nutrient Absorption, Methods of Making and Uses Thereof | FUBARA, BLESSING M | 1613 | §102§103§112 | Final Rejection | 74d overdue | Pending | May 16, 2023 |
| 18026043 | ELECTROCHEMICAL BIOSENSOR FOR TARGET ANALYTE DETECTION | SUN, CAITLYN MINGYUN | 1795 | §103 | Final Rejection | 150d overdue | Pending | Mar 13, 2023 |
| 18010878 | CLEAVAGE-AMPLIFICATION BIOSENSOR AND METHODS OF USE THEREOF | KAPUSHOC, STEPHEN THOMAS | 1683 | §102§103 | Non-Final OA | 71d | Pending | Dec 16, 2022 |
| 18001828 | Genetically Modified Bovine Herpesvirus Type 1 (BHV-1) for use to Treat Cancer | KIM, TAEYOON | 1631 | §102§103 | Final Rejection | 19d overdue | Pending | Dec 14, 2022 |
| 17997991 | CELL CULTURE SYSTEM FOR PERFUSABLE NETWORKS OF SELF-ASSEMBLED CELLS | HURST, JONATHAN M | 1799 | §102§103 | Final Rejection | — | Pending | Nov 04, 2022 |
| 17923118 | MOLECULAR TRANSPORT FOR VIRAL AGENTS | KINSEY WHITE, NICOLE ERIN | 1672 | §102§103§112 | Final Rejection | 100d overdue | Pending | Nov 03, 2022 |
| 17626295 | Bacteriophage Hydrogel Compositions and Uses Thereof | IANNUZO, NATALIE NMN | 1653 | §102§103§112DP | Non-Final OA | — | Pending | Jan 11, 2022 |
| 17333189 | Method for Diagnosing Intermittent Claudication and Chronic Limb-Threatening Ischemia | VOLKOV, ALEXANDER ALEXANDROVIC | 1677 | §112 | Non-Final OA | 19d overdue | Pending | May 28, 2021 |
| 16629204 | Risk Assessment Tool for Patients with Sepsis | POHNERT, STEVEN C | 1683 | §101§103§112 | Final Rejection | — | Pending | Jan 07, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMcmaster University has 29 pending office actions as of October 2026, spread across 22 art units and 27 examiners.
Caitlyn Mingyun Sun has the most, with 2 of Mcmaster University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
